Oppenheimer & Co’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,774
Closed -$177K 1299
2016
Q4
$177K Buy
+11,774
New +$171K 0.01% 1175
2016
Q2
Sell
-26,779
Closed -$378K 1251
2016
Q1
$378K Sell
26,779
-780
-3% -$10.5K 0.01% 856
2015
Q4
$396K Buy
27,559
+1,052
+4% +$15K 0.01% 854
2015
Q3
$357K Sell
26,507
-902
-3% -$12.9K 0.01% 928
2015
Q2
$407K Sell
27,409
-1,000
-4% -$15.2K 0.01% 969
2015
Q1
$431K Buy
28,409
+15,466
+119% +$239K 0.01% 942
2014
Q4
$199K Buy
+12,943
New +$208K 0.01% 1233

Other funds holding DIAX

Oppenheimer & Co's DIAX Position: Q1 2017 in Review

Oppenheimer & Co sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2017, closing a stake of 11,774 shares — an estimated $177K sold.

Oppenheimer & Co first reported a position in DIAX in Q4 2014 and held it in 7 quarters. The position peaked at $431K in Q1 2015. 62 funds tracked by Wall St. Rank hold DIAX as of Q1 2017.

  • Oppenheimer & Co reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2017 after selling out during the quarter.
  • Oppenheimer & Co sold 11,774 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2017, an estimated $177K.
  • Oppenheimer & Co first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 7 quarters.
  • Oppenheimer & Co's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $431K in Q1 2015.
  • 62 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2017.

Based on Oppenheimer & Co's 13F filing for Q1 2017, filed 15 May 2017.